Published in J Infect Dis on November 01, 1990
Rotavirus. Emerg Infect Dis (1999) 2.90
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04
Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis. J Clin Invest (1992) 1.60
Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol (1999) 1.22
Rotavirus vaccines: an overview. Clin Microbiol Rev (1996) 1.19
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules. Pediatrics (2016) 1.07
Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J Virol (2000) 1.03
Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J Clin Microbiol (1993) 1.00
Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children. J Virol (1993) 0.99
Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. Clin Diagn Lab Immunol (1994) 0.96
Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene. J Virol (1997) 0.94
Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J Virol (1992) 0.87
Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges. Hum Vaccin Immunother (2014) 0.87
Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assays. J Clin Microbiol (1996) 0.85
Why does the world need another rotavirus vaccine? Ther Clin Risk Manag (2008) 0.83
The Safety and Immunogenicity of Rotavirus Vaccination in Infants With Intestinal Failure. J Pediatric Infect Dis Soc (2013) 0.78
Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro. J Virol (1994) 0.75
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol (1997) 7.45
Inactivation of poliovirus in digested sludge. Appl Environ Microbiol (1976) 6.23
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Identification of the virucidal agent in wastewater sludge. Appl Environ Microbiol (1977) 3.42
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst (2001) 3.02
M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol (2001) 2.81
Inactivation of enteric viruses in wastewater sludge through dewatering by evaporation. Appl Environ Microbiol (1977) 2.70
Heat inactivation of poliovirus in wastewater sludge. Appl Environ Microbiol (1976) 2.59
Effect of cytosine arabinoside on viral-specific protein synthesis in cells infected with herpes simplex virus. J Virol (1975) 2.40
Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr (1992) 2.31
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Efficiency of human rotavirus propagation in cell culture. J Clin Microbiol (1984) 2.07
Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Intern Med J (2012) 2.02
Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study. Circulation (1995) 1.93
35Cl NMR studies of zinc adenosine diphosphate complexes. Biochem Biophys Res Commun (1967) 1.92
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol (2000) 1.64
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Mechanism of poliovirus inactivation by ammonia. J Virol (1978) 1.64
Colorectal cancer: a model for epigenetic tumorigenesis. Gut (2006) 1.62
Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest (1995) 1.58
Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology (1995) 1.56
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
Nature of the scrapie agent: evidence against a viroid. J Virol (1974) 1.48
Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol (2009) 1.47
Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology (2000) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch Virol (1996) 1.40
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatr (1999) 1.38
Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36
Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods (1991) 1.35
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35
Enteric virus and indicator bacteria levels in a water treatment system modified to reduce trihalomethane production. Appl Environ Microbiol (1984) 1.35
Effects of moisture content on long-term survival and regrowth of bacteria in wastewater sludge. Appl Environ Microbiol (1981) 1.35
Hydrogen production by Anabaena cylindrica: effects of varying ammonium and ferric ions, pH, and light. Appl Environ Microbiol (1978) 1.33
Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology (1994) 1.33
Identification of detergents as components of wastewater sludge that modify the thermal stability of reovirus and enteroviruses. Appl Environ Microbiol (1978) 1.33
Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization. Clin Chem (2000) 1.32
Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J (1997) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
Mechanism of inactivation of enteric viruses in fresh water. Appl Environ Microbiol (1986) 1.27
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol (1992) 1.25
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol (1999) 1.22
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol (1984) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J Virol (1990) 1.20
Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. J Am Coll Cardiol (1985) 1.19
pH modification of the effects of detergents on the stability of enteric viruses. Appl Environ Microbiol (1979) 1.19
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Heat inactivation of enteric viruses in dewatered wastewater sludge. Appl Environ Microbiol (1978) 1.16
Comparison of VP4 and VP7 of five murine rotavirus strains. Virology (1994) 1.15
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities. J Virol (1997) 1.13
Discovery of an agent in wastewater sludge that reduces the heat required to inactivate reovirus. Appl Environ Microbiol (1977) 1.13
Comparison of methods for recovering indigenous viruses from raw wastewater sludge. Appl Environ Microbiol (1982) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet (2009) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Induction of cytopathogenicity in mammalian cell lines challenged with culturable enteric viruses and its enhancement by 5-iododeoxyuridine. Appl Environ Microbiol (1982) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Effect of mutation in immunodominant neutralization epitopes on the antigenicity of rotavirus SA-11. J Gen Virol (1985) 1.09
Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis. Arch Virol (1996) 1.09
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Uptake of bacteriophage f2 through plant roots. Appl Environ Microbiol (1982) 1.07
Polyneuritis after Jungle Sores. Br Med J (1945) 1.07
Effects of wastewater sludge and its detergents on the stability of rotavirus. Appl Environ Microbiol (1980) 1.06
Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis (2006) 1.06
Comparison of seven kits for detection of rotavirus in fecal specimens with a sensitive, specific enzyme immunoassay. Diagn Microbiol Infect Dis (1987) 1.06
Left ventricular diastolic filling in the elderly: the cardiovascular health study. Am J Cardiol (1998) 1.06
Response of bacteria in wastewater sludge to moisture loss by evaporation and effect of moisture content on bacterial inactivation by ionizing radiation. Appl Environ Microbiol (1981) 1.06
The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer (2006) 1.06
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Evidence that microorganisms cause inactivation of viruses in activated sludge. Appl Environ Microbiol (1982) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer (2003) 1.04
Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer. Br J Cancer (2001) 1.04
Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis. Oncogene (2012) 1.04
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design. J Immunol (2001) 1.03
Inactivation of poliovirus in wastewater sludge with radiation and thermoradiation. Appl Environ Microbiol (1977) 1.03
Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J Virol (2000) 1.03